↓ Skip to main content

Treatment of Inappropriate Sexual Behavior in Dementia

Overview of attention for article published in Current Treatment Options in Neurology, August 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 501)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
33 news outlets
twitter
303 X users

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
118 Mendeley
Title
Treatment of Inappropriate Sexual Behavior in Dementia
Published in
Current Treatment Options in Neurology, August 2016
DOI 10.1007/s11940-016-0425-2
Pubmed ID
Authors

Riccardo De Giorgi, Hugh Series

Abstract

Inappropriate sexual behavior (ISB) is a relatively common and potentially disruptive form of behavior in people with dementia. It can cause considerable distress and put placements and people at risk. Yet it is poorly researched and understood. In addition to non-pharmacological approaches to management, a wide range of classes of medication has been used in ISB, and the results have been reported as single cases or short series, though none has been the subject of a randomized clinical trial, in part because of the lack of a well-defined method of observing and measuring ISB, as well as the significant ethical considerations. Pharmacological treatments for which there is low-level evidence of efficacy in the literature include antidepressants, antipsychotics, anticonvulsants, cholinesterase inhibitors, hormonal agents, and beta-blockers. None of the drugs discussed here is licensed for use in ISB, and elderly people, particularly those with dementia, are at high risk of adverse effects. Caution is advised before using medication in this group of people. It is important to consider alternative non-pharmacological treatments, as well as discussing issues of ethics and consent with those involved, before initiating treatment. It is helpful to identify and monitor target symptoms. Pharmacological treatments should be started at low dose and titrated up slowly and carefully. Nevertheless, in some situations, medication may provide a useful part of a management plan for ISB.

X Demographics

X Demographics

The data shown below were collected from the profiles of 303 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 1 <1%
Brazil 1 <1%
Unknown 116 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 12%
Other 12 10%
Student > Postgraduate 12 10%
Student > Bachelor 10 8%
Student > Ph. D. Student 9 8%
Other 23 19%
Unknown 38 32%
Readers by discipline Count As %
Medicine and Dentistry 35 30%
Psychology 12 10%
Nursing and Health Professions 11 9%
Social Sciences 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 8 7%
Unknown 44 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 486. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2024.
All research outputs
#55,285
of 25,837,817 outputs
Outputs from Current Treatment Options in Neurology
#1
of 501 outputs
Outputs of similar age
#1,129
of 375,868 outputs
Outputs of similar age from Current Treatment Options in Neurology
#1
of 6 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 501 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 375,868 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them